
- /
- Supported exchanges
- / US
- / GELS.NASDAQ
Gelteq Limited Ordinary Shares (GELS NASDAQ) stock market data APIs
Gelteq Limited Ordinary Shares Financial Data Overview
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Gelteq Limited Ordinary Shares data using free add-ons & libraries
Get Gelteq Limited Ordinary Shares Fundamental Data
Gelteq Limited Ordinary Shares Fundamental data includes:
- Net Revenue: 143 K
- EBITDA: -1 580 847
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Gelteq Limited Ordinary Shares News

Gelteq Expands U.S. Operations with Healthy Extracts Inc. as North American Fulfillment Partner
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white la...


Gelteq’s Sportsgel Brand Named Official Sponsor of the Professional Pickleball Tour and League of Australia and New Zealand
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and ma...

Gelteq Appoints Matthew Jones as Head of Sports Performance
NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) (“Gelteq” or the “Company”), a global biotechnology company that specializes in the formulation, development, and ma...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.